Amarin Corp Plc (AMRN)

[ziploc_1]

Amarin might be interested in selling Vascepa in China for 60% less than in the U.S.

QUOTE from Albert Bouria of Pfizer...
"We have an agreement already for local manufacturing of PAXLOVID in China. So we have a local partner that will make PAXLOVID for us, and then we will sell it to the Chinese market. So that's already signed. And this production is gearing up....
we applied for to be in the list basically of the reimbursed products, and we were rejected. That's correct. And I will give you all the elements about it...

"We are bringing PAXLOVID to the Chinese market.
we have a price different -- tier pricing for middle-income countries, and that's 60% to 70% lower than the price of the high-income countries. And then we have a price for the low-income countries, which is at cost. That's how we do vaccines. This is how we do PAXLOVID, the same equity principles.

So they want it lower than the lowest of the middle, and we didn't agree. They are the second highest economy in the world. And I don't think that they should pay less than Salvador, right, which is a poor country. So this is where we are now. What are the consequences of that?... unless something changes, which is one of the possibilities, and we are back in discussions with them, we will continue with the private market in China, which is significant."